SCHEMBL3808467

SCHEMBL3808467

CCCCCCCCCCCCCCCCCCNC(=O)c1c[nH]c2c(F)cccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.56
▸ HDAC1 Q13547 5/20 0.50
▸ HDAC3 O15379 4/20 0.50
▸ NAAA Q02083 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC4 P56524 1/20 0.47
▸ HDAC7 Q8WUI4 1/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC11 Q96DB2 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ HDAC9 Q9UKV0 1/20 0.47
▸ HDAC5 Q9UQL6 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ ALOX5 P09917 1/20 0.46
▸ PLA2G7 Q13093 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20647973 0.85 RAB9A (0.42) RAB9AHDAC1HDAC3NAAAALDH1A1
SCHEMBL3810676 0.80 HDAC1 (0.57) HDAC1HDAC3NAAAALDH1A1MEN1
SCHEMBL16596188 0.80 HDAC1 (0.71) HDAC1HDAC3NAAAHDAC2HDAC4
SCHEMBL29206527 0.78 GABRP (0.50) RAB9AALDH1A1HTTALOX5LMNA
SCHEMBL30877846 0.78 GABRP (0.50) RAB9AALDH1A1HTTALOX5LMNA
SCHEMBL28929321 0.77 NAAA (0.70) RAB9AHDAC1HDAC3NAAAALDH1A1
SCHEMBL26490524 0.77 ALDH1A1 (0.49) RAB9AHDAC1HDAC3NAAAALDH1A1
SCHEMBL19542266 0.76 NAAA (0.59) RAB9ANAAAALDH1A1TSHRHTT
SCHEMBL19226218 0.74 DNA2 (0.60) RAB9ANAAAALDH1A1MEN1KMT2A
SCHEMBL18229443 0.74 GABRA1 (0.63) HDAC1HDAC3NAAAHDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282735-B1 PP2A MODULATORS FOR TREATING ALZHEIMER, PARKINSON, DIABETES SIGNUM BIOSCIENCES INC (US) 2019-01-16 — — EP disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 — — US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 — — US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 — — US disclosed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 — — WO disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 — — US disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 — — US disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same PPP2CA, PPP4C, PPP6C RAB9A 3562/4885HDAC1 137/4885HDAC3 196/4885
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME PPP2CA, PPP4C, PPP6C RAB9A 3562/4885HDAC1 137/4885HDAC3 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback